Actavis plc and Forest Laboratories, Inc. (NYSE:FRX) announced that, at shareholder meetings held, all proposals related to Actavis’ planned acquisition of Forest were approved by both Actavis’ and Forest’s shareholders. Forest Laboratories, Inc. (NYSE:FRX) net profit margin is 4.50% and weekly performance is 2.97%. On last trading day company shares ended up $ 96.59. Analysts mean target price for the company is $91.00. Forest Laboratories, Inc. (NYSE:FRX) distance from 50-day simple moving average (SMA50) is 4.73%.
Johnson & Johnson (NYSE:JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, July 15th, to review second-quarter results. Alex Gorsky, Chairman of the Board of Directors and Chief Executive Officer; Dominic Caruso, Vice President, Finance and Chief Financial Officer; Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson and Worldwide Chairman, Pharmaceuticals; Joaquin Duato, Worldwide Chairman, Pharmaceuticals; and Louise Mehrotra, Vice President, Investor Relations, will host the call. Johnson & Johnson (NYSE:JNJ) shares fell -0.51% in last trading session and ended the day on $101.93. Gross Margin is 69.10% and its return on assets is 11.60%. Johnson & Johnson (NYSE:JNJ) quarterly performance is 9.26%.
Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) reached settlement deals with four generic drug companies resolving a patent dispute over the company’s sleep disorder drug Nuvigil. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares moved down -0.48% in last trading session and was closed at $51.45, while trading in range of $50.99 – $51.78. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) year to date (YTD) performance is 30.22%.
On June 15, Vale SA(ADR) (NYSE:VALE), Brazil’s biggest mining company, said that 400 members of the Xikrin tribe have been blocking since Thursday morning the main entrance to its Onca Puma nickel mine in Para state. It said the Indians are seeking to modify an agreement to mitigate the mine’s impact on its community’s development. Vale SA (ADR) (NYSE:VALE) ended the last trading day at $12.63. Company weekly volatility is calculated as 1.71% and price to cash ratio as 9.10. Vale SA (ADR) (NYSE:VALE) showed a negative weekly performance of -4.39%.
On June 12, Growblox Sciences Inc (OTCMKTS:GBLX) announced that it’s wholly owned subsidiary GB Sciences Nevada, LLC obtained a medical marijuana license in Clark County, Nevada. Commissioners only awarded 18 licenses out of 79 final applicants – a three day hearing was conducted in order to make the selections after an unorthodox process which included 6-minute “pitches” to decision makers. Growblox Sciences Inc (OTCMKTS:GBLX) On last trading day company shares ended up $1.33.